Search results for " insulin"

showing 10 items of 237 documents

The Role of the Heme Oxygenase System in the Metabolic Syndrome

2014

Molecular chaperones and the heat shock response play a major role in the maintenance of cellular homeostasis under various pathological conditions. In particular, their role is to regulate protein conformation, protect proteins from misfolding and aggregation, and maintain signalling and organellarnetworks. Among variousheat shock proteins, Hsp32 also known as heme oxygenase-1 (HO-1), has demonstrated an important role in metabolic syndrome. In particular, the HO system seems to play a major role in the complex pathophysiological cascade involved in insulin resistance mechanisms, and adipocyte functions as measured by the release of important adipokynes. The aim of the present review is to…

Cellular homeostasisBiologychemistry.chemical_compoundProtein structureInsulin resistanceDrug DiscoverymedicineHumansMetabolic syndrome heme oxygenase insulin sensitivity adiponectin heat shock proteins.Heat shockHemeHeat-Shock ProteinsMetabolic SyndromePharmacologySettore BIO/16 - Anatomia Umanamedicine.diseaseCell biologyHeme oxygenasechemistryBiochemistryShock (circulatory)Insulin Resistancemedicine.symptomMetabolic syndromeHeme Oxygenase-1Molecular Chaperones
researchProduct

Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guidelin…

2006

OBJECTIVE: The Androgen Excess Society (AES) charged a task force to review all available data and recommend an evidence-based definition for polycystic ovary syndrome (PCOS), whether already in use or not, to guide clinical diagnosis and future research. PARTICIPANTS: Participants included expert investigators in the field. EVIDENCE: Based on a systematic review of the published peer-reviewed medical literature, by querying MEDLINE databases, we tried to identify studies evaluating the epidemiology or phenotypic aspects of PCOS. CONSENSUS PROCESS: The task force drafted the initial report, following a consensus process via electronic communication, which was then reviewed and critiqued by …

ConsensusAndrogensHumansFemaleGuidelines as TopicHyperandrogenismSocieties Medicalpolycystic ovary syndrome cardiovascular risk insulin resistancePolycystic Ovary SyndromeThe Journal of clinical endocrinology and metabolism
researchProduct

The relationship between health-related quality of life and melancholic depressive symptoms is modified by brain insulin receptor gene network

2021

AbstractTo investigate whether expression-based polygenic risk scores for the insulin receptor gene network (ePRS-IRs) modifiy the association between type of depressive symptoms and health-related quality of life (HRQoL). This cross-sectional study includes 1558 individuals from the Helsinki Birth Cohort Study. Between 2001 and 2004, the Short Form-36 questionnaire was employed to assess mental and physical components of HRQoL and Beck Depression Inventory (BDI) to assess depressive symptoms. Depressive symptoms were categorized into minimal (BDI < 10), non-melancholic and melancholic types of depression. The ePRS-IRs were calculated for the hippocampal (hePRS-IR) and the mesocorticolim…

DISORDERMaleglukoosiaineenvaihduntaelämänlaatuBody Mass Index0302 clinical medicineQuality of lifeSurveys and QuestionnairesMedicineGene Regulatory NetworksDepression (differential diagnoses)METABOLIC SYNDROME2. Zero hunger0303 health sciencesMultidisciplinarydiabetesDepressionQDiabetesRBrainASSOCIATIONriskitekijätMiddle AgedhumanitiesPREVALENCEINVENTORY-IIMedicineFemalegeneettiset tekijätmasennusQuality of lifeRiskmedicine.medical_specialtySciencePopulation stratificationRisk AssessmentArticle03 medical and health sciencesAntigens CDInternal medicineSadnessHumansGenetic Predisposition to DiseaseMETAANALYSISDepressive symptoms030304 developmental biologyAgedHealth related quality of lifePsychiatric Status Rating ScalesDepressive Disorderbusiness.industryterveydentilaInsulin Receptor GeneBeck Depression InventoryReceptor InsulinPSYCHOMETRIC PROPERTIESCross-Sectional StudiesGene Expression Regulation3121 General medicine internal medicine and other clinical medicinebusinessBody mass indexRESISTANCE030217 neurology & neurosurgery
researchProduct

Utilizzo dell’insulina detemir in una casistica di donne affette da diabete tipo 1 in gravidanza: uno studio caso-controllo retrospettivo.

2012

Detemir insulina diabete tipo 1 gravidanza
researchProduct

Self-concept and adaptation to illness in pediatric diabetic patients

2014

Nuestro objetivo es estudiar el autoconcepto y la adaptación a la enfermedad en pacientes pediátricos diabéticos. Como instrumentos de evaluación se utilizaron el registro ad-hoc para las variables sociodemográficas y de enfermedad, el cuestionario de Autoconcepto Garley (CAG) y cuestionario de respuesta adaptativa a la enfermedad en pacientes diabéticos. La muestra constó de 23 sujetos evaluados en un único momento de medida, todos ellos niños y adolescentes entre 8 y 16 años de edad. Los resultados muestran cómo aproximadamente el 50% de niños y adolescentes con diabetes tipo I presentan un autoconcepto bajo en la mayoría de las dimensiones estudiadas, destacando cómo cerca del 30% de los…

Diabetes mellitus insulinodependienteAutoconceptoAdaptaciónSelf-conceptDiseaseAdaptationInsulin-dependent diabetesEnfermedad
researchProduct

Halloysite nanotubes for efficient loading, stabilization and controlled release of insulin

2018

Hypothesis: Oral insulin administration is not actually effective due to insulin rapid degradation, inactivation and digestion by proteolytic enzymes which results in low bioavailability. Moreover insulin is poorly permeable and lack of lipophilicity. These limits can be overcome by the loading of protein in some nanostructured carrier such as halloysite nanotubes (HNTs). Experiments: Herein we propose an easy strategy to obtain HNT hybrid materials for the delivery of insulin. We report a detailed description on the thermal behavior and stability of insulin loaded and released from the HNTs hybrid by the combination of several techniques. Findings: Release experiments of insulin from the H…

Dichroismmedicine.medical_treatmentHalloysite nanotube02 engineering and technology01 natural sciencesBiochemistryNanocompositesChitosanchemistry.chemical_compoundColloid and Surface ChemistryDrug StabilityProtein stabilityHalloysite nanotube (HNTs)InsulinTransdermalSettore CHIM/02 - Chimica FisicaDrug CarriersNanotubesProteolytic enzymes021001 nanoscience & nanotechnologyControlled releaseSurfaces Coatings and FilmsElectronic Optical and Magnetic MaterialsEnzyme inhibitionAluminum SilicatesBionanocomposite film0210 nano-technologyHybrid materialBionanocomposite hybridSurface PropertiesDrug Compoundingengineering.materialCircular dichroism data010402 general chemistrySustained release InsulinAdministration CutaneousHalloysiteBiomaterialsKaolinitemedicineParticle SizeHybrid materialChitosanInsulinBiomedical applicationMedical applicationYarn Bio-nanocompositeMembranes Artificial0104 chemical sciencesNanotubeDrug LiberationHalloysite nanotubes Insulin Protein stability Sustained release Bionanocomposite hybridchemistryChemical engineeringDelayed-Action PreparationsengineeringClayNanocarriersSustained release
researchProduct

The therapeutic modulation of atherogenic dyslipidemia and inflammatory markers in the metabolic syndrome: what is the clinical relevance?

2008

The metabolic syndrome consists of a constellation of clinical and biochemical risk factors that cluster together and heighten the risk for atherogenesis, cardiovascular diseases, and diabetes. Established risk cardiovascular factors like hypertension, atherogenic dyslipidaemia, and glucose intolerance occur in the setting of insulin resistance and central adiposity, with genetic and environmental influences modulating the ultimate risk. Chronic insults to the endothelium take its toll in the form of silent as well as clinically evident cardiovascular events. The cellular and vascular accompaniments have shed some light into the underlying pathophysiology. Heightened, low-grade inflammatory…

Endocrinology Diabetes and Metabolismmedicine.medical_treatmentInflammationMetabolic syndrome Insulin resistance Dyslipidemia Atherosclerosis Adipocytokinesmedicine.disease_causeTargeted therapyEndocrinologyInsulin resistanceRisk FactorsDiabetes mellitusHeredityInternal MedicinemedicineHumansClinical significanceDyslipidemiasInflammationMetabolic Syndromebusiness.industryCholesterol LDLGeneral MedicineAtherosclerosismedicine.diseaseC-Reactive ProteinImmunologymedicine.symptomMetabolic syndromebusinessBiomarkersDyslipidemiaActa Diabetologica
researchProduct

Modulation of Diabetes by Natural Products and Medicinal Plants via Incretins

2019

Incretins are metabolic hormones released after a meal that increase insulin secretion from pancreatic β-cells. The two main incretins are the intestinal peptides glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide. Both induce a decrease in glycemia, slow down the absorption of nutrients, and are inactivated by the enzyme dipeptidyl peptidase-4. Recently, incretin-based therapies have become a useful tool to treat diabetic patients, and different studies have focused on the identification of glucagon-like peptide-1 receptor agonists, including those of natural origin. This review focuses on the new findings of medicinal plants and natural products as possible active ag…

Enfermedad cardiovascularPharmaceutical SciencePharmacology01 natural sciencesAnalytical Chemistry//purl.org/becyt/ford/1 [https]Tratamiento médicoDPP-4Drug DiscoveryReceptorchemistry.chemical_classificationGIPGLUCAGON-LIKE PEPTIDE-1digestive oral and skin physiologyGlucagon-like peptide-1Diabetes mellitus tipo 2HomeopatíaINCRETINSMolecular MedicineCIENCIAS NATURALES Y EXACTAShormones hormone substitutes and hormone antagonistsendocrine systemOtras Ciencias BiológicasIncretinIncretinsCiencias BiológicasDiabetes mellitusDiabetes MellitusmedicineAnimalsHumansHypoglycemic Agents//purl.org/becyt/ford/1.6 [https]Dipeptidyl peptidase-4PharmacologyBiological ProductsPlants MedicinalGuar gum010405 organic chemistryOrganic ChemistryGLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDEmedicine.diseaseDIPEPTIDYL PEPTIDASE-40104 chemical sciences010404 medicinal & biomolecular chemistryEnzymeComplementary and alternative medicinechemistryGLP-1PhytotherapyHormone
researchProduct

Correction: DAPIT Over-Expression Modulates Glucose Metabolism and Cell Behaviour in HEK293T Cells

2015

Introduction Diabetes Associated Protein in Insulin-sensitive Tissues (DAPIT) is a subunit of mitochondrial ATP synthase and has also been found to associate with the vacuolar H+-ATPase. Its expression is particularly high in cells with elevated aerobic metabolism and in epithelial cells that actively transport nutrients and ions. Deletion of DAPIT is known to induce loss of mitochondrial ATP synthase but the effects of its over-expression are obscure. Results In order to study the consequences of high expression of DAPIT, we constructed a transgenic cell line that constitutively expressed DAPIT in human embryonal kidney cells, HEK293T. Enhanced DAPIT expression decreased mtDNA content and …

Epithelial-Mesenchymal Transitionmitochondrial metabolismBiolääketieteet - BiomedicineCellActive Transport Cell NucleusGene DosageRespiratory chainlcsh:MedicineGene ExpressionMitochondrionta3111glukoosiNeoplasmsmedicineHumansLactic Acidglucoselcsh:ScienceTranscription factorMultidisciplinaryATP synthasebiologyCell growthta1184lcsh:RHEK 293 cellsCorrectionMitochondrial Proton-Translocating ATPasesMitochondriaCell biologyHEK293 CellsDiabetes Associated Protein in Insulin-sensitive Tissuesmedicine.anatomical_structureCell culturebiology.proteinATP synthaselcsh:QResearch ArticlePLOS ONE
researchProduct

Old and new basal insulin formulations: understanding pharmacodynamics is still relevant in clinical practice.

2013

Long-acting insulin analogues have been developed to mimic the physiology of basal insulin secretion more closely than human insulin formulations (Neutral Protamine Hagedorn, NPH). However, the clinical evidence in favour of analogues is still controversial. Although their major benefit as compared with NPH is a reduction in the hypoglycaemia risk, some cost/effectiveness analyses have not been favourable to analogues, largely because of their higher price. Nevertheless, these new formulations have conquered the insulin market. Human insulin represents currently no more than 20% of market share. Despite (in fact because of) the widespread use of insulin analogues it remains critical to anal…

Evidence-Based Medicinebusiness.industryEndocrinology Diabetes and MetabolismBasal insulinInsulinmedicine.medical_treatmentChemistry PharmaceuticalInsulin Short-ActingType 2 diabetesPharmacologymedicine.diseaseClinical PracticeClinical trialInsulin Long-ActingEndocrinologyDiabetes Mellitus Type 1Diabetes Mellitus Type 2Diabetes mellitusPharmacodynamicsInternal MedicinemedicineHumansHypoglycemic AgentsIn patientbusinessDiabetes, obesitymetabolism
researchProduct